semorinemab

News
Closeup of X-ray photography of human brain

AC Immune poleaxed on Alzheimer’s study fail

Shares in AC Immune have collapsed after partner Genentech revealed its tau-targeting Alzheimer’s drug semorinemab had flunked a phase 2 trial in Alzheimer’s disease (AD). The Swis